Advertisement
Advertisement
U.S. Markets open in 5 hrs 33 mins
S&P Futures
4,157.75 +11.00 (+0.27%) Dow Futures
32,842.00 +85.00 (+0.26%) Nasdaq Futures
13,280.25 +51.50 (+0.39%) Russell 2000 Futures
1,926.20 +4.40 (+0.23%) Crude Oil
89.55 +0.54 (+0.61%) Gold
1,794.50 +3.30 (+0.18%)
Savara Inc. (SVRA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 1.7700 |
| Open | 1.7500 |
| Bid | 0.0000 x 1000 |
| Ask | 0.0000 x 2200 |
| Day's Range | 1.7400 - 1.7700 |
| 52 Week Range | 1.0200 - 1.9100 |
| Volume | |
| Avg. Volume | 195,217 |
| Market Cap | 198.132M |
| Beta (5Y Monthly) | 0.92 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4100 |
| Earnings Date | Nov 12, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.00 |
- Simply Wall St.
What Kind Of Investors Own Most Of Savara Inc. (NASDAQ:SVRA)?
If you want to know who really controls Savara Inc. ( NASDAQ:SVRA ), then you'll have to look at the makeup of its...
- Business Wire
Savara Announces Acceptance of Three Abstracts at the European Respiratory Society (ERS) International Congress 2022
AUSTIN, Texas, July 11, 2022--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the acceptance of three abstracts for poster presentation at the ERS International Congress 2022 to be held in-person and virtually, September 4-6, 2022 in Barcelona, Spain.
- Zacks
Zacks.com featured highlights include Savara, The LGL Group, and Harte Hanks
Savara, The LGL Group, and Harte Hanks are part of zacks Screen of the Week article.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
